• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高剂量静脉注射琥珀酸半氢化泼尼松治疗急性白塞氏视网膜病变

High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behçet retinitis.

作者信息

Reed J B, Morse L S, Schwab I R

机构信息

Department of Ophthalmology, University of California, Davis, Sacramento 95816, USA.

出版信息

Am J Ophthalmol. 1998 Mar;125(3):409-11. doi: 10.1016/s0002-9394(99)80163-9.

DOI:10.1016/s0002-9394(99)80163-9
PMID:9512170
Abstract

PURPOSE

To report the response of acute Behçet retinitis to high-dose corticosteroids.

METHOD

Case report. A 58-year-old man with Behçet disease and severe bilateral glaucoma experienced a sudden decrease of visual acuity to counting fingers in his (better-seeing) left eye. Examination disclosed hypopyon uveitis and an infiltrative retinitis threatening the fovea. He received intravenous methylprednisolone hemisuccinate, 1 gram per hour on each of 3 successive days, followed by oral prednisone and cyclosporine.

RESULTS

The retinal infiltrate disappeared within 24 hours. Visual acuity improved to LE, 20/400 by day 5 and returned to LE, 20/30 after 3 months. A visual field demonstrated a scotoma corresponding to the location of the previous retinitis.

CONCLUSION

High-dose intravenous methylprednisolone can reverse severe vision loss in acute Behçet retinitis.

摘要

目的

报告大剂量皮质类固醇对急性白塞氏视网膜病变的疗效。

方法

病例报告。一名58岁患有白塞氏病和严重双侧青光眼的男性,其(视力较好的)左眼视力突然降至只能数指。检查发现前房积脓性葡萄膜炎和累及黄斑的浸润性视网膜病变。他接受了静脉注射半琥珀酸甲泼尼龙,连续3天每天每小时1克,随后口服泼尼松和环孢素。

结果

视网膜浸润在24小时内消失。视力在第5天提高到左眼20/400,3个月后恢复到左眼20/30。视野检查显示与先前视网膜病变部位相对应的暗点。

结论

大剂量静脉注射甲泼尼龙可逆转急性白塞氏视网膜病变导致的严重视力丧失。

相似文献

1
High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behçet retinitis.高剂量静脉注射琥珀酸半氢化泼尼松治疗急性白塞氏视网膜病变
Am J Ophthalmol. 1998 Mar;125(3):409-11. doi: 10.1016/s0002-9394(99)80163-9.
2
Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease.低剂量干扰素α2a治疗白塞病相关严重葡萄膜炎的长期疗效与安全性。
Am J Ophthalmol. 2008 Dec;146(6):837-44.e1. doi: 10.1016/j.ajo.2008.08.038.
3
Low-dose interferon alfa-2a therapy in severe uveitis associated with Behçet disease.低剂量干扰素α-2a治疗与白塞病相关的严重葡萄膜炎。
Am J Ophthalmol. 2009 Jun;147(6):1109-10; author reply 1110. doi: 10.1016/j.ajo.2009.03.009.
4
High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study.高剂量静脉注射类固醇脉冲疗法治疗白塞病眼部受累:一项初步双盲对照研究。
Int J Rheum Dis. 2017 Sep;20(9):1269-1276. doi: 10.1111/1756-185X.13095. Epub 2017 May 19.
5
Acute optic neuropathy in Behçet disease.白塞病中的急性视神经病变
Eur J Ophthalmol. 2004 Nov-Dec;14(6):578-80.
6
Influenza retinitis: association with influenza encephalitis.
Ophthalmologica. 2005 Mar-Apr;219(2):119-21. doi: 10.1159/000083273.
7
Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy.英夫利昔单抗治疗贝赫切特病患者的眼部炎症发作减少及眼底视网膜和视盘血管渗漏减轻。
Br J Ophthalmol. 2011 Sep;95(9):1245-50. doi: 10.1136/bjo.2010.194464. Epub 2010 Dec 22.
8
Efficacy of Infliximab for Early Remission Induction in Refractory Uveoretinitis Associated with Behçet Disease: A 2-year Follow-up Study.英夫利昔单抗诱导难治性白塞病相关葡萄膜炎早期缓解的疗效:一项为期2年的随访研究。
Ocul Immunol Inflamm. 2017 Feb;25(1):46-51. doi: 10.1080/09273948.2016.1239746. Epub 2016 Oct 21.
9
Immune keratitis: An unusual primary presentation of neuro-Behçet's disease.免疫性角膜炎:神经白塞病一种不寻常的首发表现。
Eur J Ophthalmol. 2019 Jul;29(4):NP5-NP8. doi: 10.1177/1120672118803534. Epub 2018 Oct 7.
10
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.一项关于皮质类固醇治疗急性视神经炎的随机对照试验。视神经炎研究组。
N Engl J Med. 1992 Feb 27;326(9):581-8. doi: 10.1056/NEJM199202273260901.

引用本文的文献

1
Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections.对抗“怪物”:将宿主损伤框架应用于人类中枢神经系统感染
mBio. 2016 Jan 26;7(1):e01906-15. doi: 10.1128/mBio.01906-15.
2
High-dose intravenous corticosteroids for ocular inflammatory diseases.大剂量静脉用皮质类固醇治疗眼部炎性疾病。
Ocul Immunol Inflamm. 2012 Apr;20(2):91-9. doi: 10.3109/09273948.2011.646382.
3
Emerging drugs for uveitis.治疗葡萄膜炎的新兴药物。
Expert Opin Emerg Drugs. 2011 Jun;16(2):309-22. doi: 10.1517/14728214.2011.537824. Epub 2011 Jan 6.
4
High dose intravenous steroid therapy for severe posterior segment uveitis in Behçet's disease.高剂量静脉注射类固醇疗法治疗白塞病严重后段葡萄膜炎。
Br J Ophthalmol. 2002 May;86(5):521-3. doi: 10.1136/bjo.86.5.521.